Effect of statins and ACE inhibitors on the metabolome in the Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT) cohort
Rattachement africain : it, gb, au, sg, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Adolescence represents a pivotal period for the development of early diabetes-related vascular complications, primarily driven by chronic hyperglycemia and associated metabolic disturbances. Metabolomics provides a promising tool to identify biomarkers reflecting these early changes. The present study compared metabolomic profiles between adolescents with and without type 1 diabetes and assessed the impact of glycemia and short-term treatment with statins and/or ACE inhibitors on metabolite trajectories. Metabolomic data were obtained via the Nightingale platform from 341 adolescents with type 1 diabetes from the AdDIT study and 81 age- and sex-matched peers without diabetes. Two hundred and forty-nine metabolites, with 45 prioritized due to well-established links with cardiovascular disease- including lipid subfractions, amino acids, ketone bodies, and markers of renal function and inflammation-were measured at a mean age of 14.0 ± 1.8 years and re-assessed after 3.5 years in those with diabetes. At baseline, significant differences were observed in glucose, ketone bodies, amino acids, and lipid classes. Over time, adolescents with diabetes showed increases in lipid subfractions, acetoacetate, and GlycA, with HbA1c positively associated with atherogenic lipidome components. Findings from the trial arm provided strong evidence that statins attenuated rises in LDL-cholesterol (1.90 [1.79, 2.01] vs. 2.38 [2.28, 2.49] mmol/l), and weaker evidence suggestive of a small effect of ACE inhibitors in preserving HDL-cholesterol (1.50 [1.45, 1.54] vs. 1.39 [1.34, 1.43] mmol/l). These findings suggest widespread glycemia-related metabolomic perturbations in adolescents with type 1 diabetes, partially mitigated by statins and ACE inhibitors, supporting their cardioprotective role.Clinical registration: ClinicalTrials.gov ID NCT01581476 (13/04/2012) https://clinicaltrials.gov/study/NCT01581476 .
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effect of statins and ACE inhibitors on the metabolome in the Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT) cohort
- Date Crossref
- 29/04/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Modena and Reggio Emilia pays non établi dans la noticeUniversité ou école supérieure
-
University College London Institute of Cardiovascular Science pays non établi dans la noticeUniversité ou école supérieure
-
The University of Sydney Discipline of Child and Adolescent Health pays non établi dans la noticeUniversité ou école supérieure
-
Children's Hospital at Westmead pays non établi dans la noticeÉtablissement de santé
-
Royal Children's Hospital Department of Endocrinology and Diabetes pays non établi dans la noticeÉtablissement de santé
-
The University of Melbourne pays non établi dans la noticeUniversité ou école supérieure
-
Murdoch Children's Research Institute pays non établi dans la noticeOrganisation à but non lucratif
-
National University of Singapore Duke-NUS Medical School pays non établi dans la noticeUniversité ou école supérieure
-
Duke-NUS Medical School pays non établi dans la noticeUniversité ou école supérieure
-
Women's and Children's Hospital pays non établi dans la noticeÉtablissement de santé
-
Evelina London Children's Healthcare pays non établi dans la noticeÉtablissement de santé
-
Hospital for Sick Children Division of Endocrinology pays non établi dans la noticeÉtablissement de santé
University of Modena and Reggio Emilia, Institute of Cardiovascular Science — University College London et Discipline of Child and Adolescent Health — The University of Sydney, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.